Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel

NCT06997380 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of intradermal injections of the medical device - hyaluronic acid with the addition of lecithin - in a population of participants with thin, dry, and sagging facial skin.

Conditions

  • Skin Aging
  • Skin Wrinkling
  • Facial Skin Laxity
  • Facial Wrinkles

Interventions

DEVICE

Injection of the investigational product via needle

A hyaluronic acid solution (concentration 2.2%) with the addition of lecithin in the form of liposomes (concentration 0.08%) via needle

DEVICE

Injection of the investigational product via cannula

A hyaluronic acid solution (concentration 2.2%) with the addition of lecithin in the form of liposomes (concentration 0.08%) via cannula

PROCEDURE

Clinical assessment

Clinical assessment of facial skin condition

PROCEDURE

Ultrasound measurement

Ultrasound measurement of facial skin thickness

PROCEDURE

Multispectral imaging

Multispectral imaging and analysis of facial skin

Sponsors & Collaborators

  • Biovico Sp. z o.o.

    lead INDUSTRY

Principal Investigators

  • Agnieszka Sirocka

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-23
Primary Completion
2025-11-07
Completion
2025-11-07

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06997380 on ClinicalTrials.gov